Brief article outlining the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris

medicalxpress.com/news/2018-04-hepatitis...ation-treatment.html